| Literature DB >> 32978750 |
Ilaria Mulas1, Valeria Putzu2, Gesuina Asoni2, Daniela Viale2, Irene Mameli2, Massimiliano Pau3.
Abstract
AIM: The main purpose of the present study was to verify the feasibility of wearable inertial sensors (IMUs) in a clinical setting to screen gait and functional mobility in Italian older persons. In particular, we intended to verify the capability of IMUs to discriminate individuals with and without cognitive impairments and assess the existence of significant correlations between mobility parameters extracted by processing trunk accelerations and cognitive status.Entities:
Keywords: Accelerometer; Functional mobility; Gait; Inertial measurement unit (IMU); Older adults; Timed-up-and-go (TUG)
Mesh:
Year: 2020 PMID: 32978750 PMCID: PMC7518096 DOI: 10.1007/s40520-020-01715-9
Source DB: PubMed Journal: Aging Clin Exp Res ISSN: 1594-0667 Impact factor: 3.636
Participants’ anthropometric and clinical features
| HC-YO | HC-OO | CI-YO | CI-OO | |
|---|---|---|---|---|
| Participants # (F, M) | 64 (43F, 21 M) | 78 (44F, 34 M) | 28 (19F, 9 M) | 43 (27F, 16 M) |
| Age (years) | 71.9 ± 2.3 | 80.7 ± 2.5 | 71.3 ± 2.9 | 81.5 ± 4.2 |
| Body mass (kg) | 66.1 ± 12.8 | 65.4 ± 12.1 | 62.5 ± 12.3 | 61.5 ± 14.6 |
| Height (cm) | 158.8 ± 7.5 | 160.5 ± 7.9 | 159.9 ± 9.5 | 157.0 ± 8.6 |
| Years of education | 11.6 ± 4.4 | 8.2 ± 4.5 | 8.3 ± 4.2 | 5.7 ± 2.7 |
| Diagnoses and medical conditions, | ||||
| Depressive disorders | 5 (8%) | 9 (11%) | 7 (25%) | 8 (19%) |
| Diabetes and metabolic syndrome | 18 (28%) | 22 (29%) | 13 (46%) | 13 (30%) |
| Hypertension | 25 (39%) | 32 (41%) | 13 (46%) | 30 (70%) |
| Cardiovascular diseases | 25 (38%) | 27 (35%) | 15 (53%) | 27 (63%) |
| Musculoskeletal diseases | 30 (46%) | 36 (46%) | 11 (40%) | 25 (59%) |
| Routine prescription medications, | ||||
| Benzodiazepines | 5 (8%) | 22 (28%) | 5 (18%) | 5 (11%) |
| Beta-blockers | 19 (23%) | 22 (28%) | 6 (21%) | 11 (26%) |
| Antidepressants | 5 (8%) | 11 (14%) | 8 (29%) | 10 (22%) |
| Diuretics | 7 (11%) | 22 (28%) | 8 (29%) | 14 (33%) |
| Analgesics | 0 (0%) | 4 (5%) | 2 (7%) | 0 (0%) |
| Neuroleptics | 5 (8%) | 0 (0%) | 8 (29%) | 16 (37%) |
| ACE-R (overall) | 90.9 ± 3.4 | 77.6 ± 7.3 | 57.6 ± 19.9 | 38.2 ± 17.1 |
Values are expressed as mean ± SD
ACE-R Addenbrooke’s Cognitive Examination (revised), HC healthy controls, CI cognitively impaired, YO young–old, OO old–old
Spatio-temporal parameters of gait measured with the inertial sensor. Values are expressed as mean ± SD
| HC-YO | HC-OO | CI-YO | CI-OO | |||||
|---|---|---|---|---|---|---|---|---|
| Raw | Normalized | Raw | Normalized | Raw | Normalized | Raw | Normalized | |
| Gait speed (m s−1) | 1.10 ± 0.14 | 0.69 ± 0.09 | 0.95 ± 0.21a | 0.59 ± 0.13 a | 0.79 ± 0.25a,b | 0.50 ± 0.15 a | 0.60 ± 0.28a,b,c | 0.38 ± 0.18a,b,c |
| Stride length (m) | 1.16 ± 0.15 | 0.73 ± 0.09 | 1.05 ± 0.19a | 0.65 ± 0.12 | 0.90 ± 0.25a | 0.56 ± 0.15a | 0.73 ± 0.29a,b,c | 0.46 ± 0.18a,b |
| Cadence (steps min−1) | 114.42 ± 8.28 | 72.25 ± 6.60 | 109.87 ± 9.65 | 68.69 ± 7.59 | 106.58 ± 13.31a | 67.07 ± 10.43 | 98.88 ± 12.32a,b | 63.16 ± 8.82a,b |
| Stance phase (% of the gait cycle) | 60.19 ± 1.79 | 60.66 ± 2.07 | 61.11 ± 1.74 | 61.94 ± 2.12a,b | ||||
| Swing phase (% of the gait cycle) | 39.81 ± 1.80 | 39.36 ± 2.04 | 38.87 ± 1.74 | 38.06 ± 2.15a,b | ||||
| Double support phase (% of the gait cycle) | 20.42 ± 1.85 | 21.28 ± 2.00 | 22.24 ± 1.73 | 23.92 ± 2.10a,b | ||||
| Walk ratio [cm (steps min−1)−1] | 0.51 ± 0.08 | 0.48 ± 0.09 | 0.42 ± 0.11a | 0.37 ± 0.14a,b | ||||
HC healthy controls, CI cognitively impaired, YO young–old, OO old–old, iTUG instrumented Timed Up and Go
aSignificant difference vs. HC-YO after Bonferroni correction
bSignificant difference vs. HC-OO after Bonferroni correction
cSignificant difference vs. CI-YO after Bonferroni correction
iTUG parameters measured with the inertial sensor
| HC-YO | HC-OO | CI-YO | CI-OO | |
|---|---|---|---|---|
| iTUG duration (s) | 11.1 ± 1.7 | 12.3 ± 2.0 | 15.0 ± 2.9a | 21.7 ± 8.5a,b,c |
| Sit-to-stand time (s) | 1.5 ± 0.3 | 1.5 ± 0.2 | 2.2 ± 1.1a,b | 2.2 ± 0.9a,b |
| Intermediate 180° turn time (s) | 2.2 ± 0.4 | 2.5 ± 0.7 | 2.7 ± 0.6 | 3.9 ± 1.4a,b |
| Final 180° turn time (s) | 1.7 ± 0.5 | 2.0 ± 0.7 | 2.0 ± 0.6 | 2.7 ± 1.3a,b,c |
| Stand-to-sit time (s) | 0.9 ± 0.3 | 0.9 ± 0.3 | 1.3 ± 0.6a,b | 1.4 ± 0.6a,b |
Values are expressed as mean ± SD
HC healthy controls, CI cognitively impaired, YO young–old, OO old–old, iTUG instrumented Timed Up and Go
aSignificant difference vs. HC-YO after Bonferroni correction
bSignificant difference vs. HC-OO after Bonferroni correction
cSignificant difference vs. CI-YO after Bonferroni correction;
Spearman’s coefficients for the correlations between ACE-R score and gait/functional mobility parameters
| Variables | Rho value | ||
|---|---|---|---|
| ACE-R vs | Gait parameters | Gait speed | 0.580† |
| Stride length | 0.538† | ||
| Cadence | 0.436† | ||
| Stance phase | − 0.294† | ||
| Swing phase | 0.293† | ||
| Double support phase | − 0.286† | ||
| Walk ratio | 0.406† | ||
| iTUG parameters | iTUG duration | − 0.662† | |
| Sit-to-stand time | − 0.382† | ||
| Intermediate 180° turn time | − 0.473† | ||
| Final 180° turn time | − 0.329† | ||
| Stand-to-sit time | − 0.350† | ||
ACE-R Addenbrooke’s Cognitive Examination (revised), iTUG instrumented Timed Up and Go
†p < 0.001
Fig. 1Trend of gait parameters across the groups tested. Error bars indicate standard deviation
Fig. 2Trend of iTUG parameters across the groups tested. Error bars indicate standard deviation